Drug: HALOPERIDOL. Injury: Neuroleptic malignant syndrome Quarter: 2016Q3
Total Records: 16 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 102534862 | HALOPERIDOL. | Neuroleptic malignant syndrome | BRISTOL MYERS SQUIBB | 56.00 YR | M | 0 | 20160729 | DE |
| 125268661 | HALOPERIDOL. | Neuroleptic malignant syndrome | 63.00 YR | F | 55 KG | 20160701 | US | |
| 125484071 | HALOPERIDOL. | Neuroleptic malignant syndrome | 84.00 YR | M | 77 KG | 20160711 | US | |
| 125989171 | HALOPERIDOL. | Neuroleptic malignant syndrome | APOTEX | 42.00 YR | M | 0 | 20160726 | US |
| 126030631 | HALOPERIDOL. | Neuroleptic malignant syndrome | TEVA | 38.00 YR | F | 0 | 20160728 | GB |
| 126068842 | HALOPERIDOL. | Neuroleptic malignant syndrome | PFIZER | 49.00 YR | F | 0 | 20160811 | IT |
| 126125941 | HALOPERIDOL. | Neuroleptic malignant syndrome | ABBVIE | 21.00 YR | M | 0 | 20160801 | COUNTRY NOT SPECIFIED |
| 126131021 | HALOPERIDOL. | Neuroleptic malignant syndrome | RANBAXY | 34.00 YR | M | 0 | 20160802 | US |
| 126132332 | HALOPERIDOL. | Neuroleptic malignant syndrome | ASTRAZENECA | 49.00 YR | F | 0 | 20160811 | IT |
| 126171961 | HALOPERIDOL. | Neuroleptic malignant syndrome | ZYDUS PHARM | 42.00 YR | M | 0 | 20160803 | US |
| 126193461 | HALOPERIDOL. | Neuroleptic malignant syndrome | MYLAN | 0.00 | 0 | 20160803 | IT | |
| 126359832 | HALOPERIDOL. | Neuroleptic malignant syndrome | ROCHE | 49.00 YR | F | 0 | 20160822 | IT |
| 126445591 | HALOPERIDOL. | Neuroleptic malignant syndrome | SANDOZ | 49.00 YR | F | 0 | 20160811 | IT |
| 126514575 | HALOPERIDOL. | Neuroleptic malignant syndrome | TEVA | 49.00 YR | F | 0 | 20160902 | IT |
| 127471292 | HALOPERIDOL. | Neuroleptic malignant syndrome | JOHNSON AND JOHNSON | 21.00 YR | M | 0 | 20160917 | US |
| 127513311 | HALOPERIDOL. | Neuroleptic malignant syndrome | FDA-CTU | 70.00 YR | M | 86 KG | 20160916 | US |
Total Records: 16 Number of Pages: 1